June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Stable production of hESC/iPSC-derived retinal progenitor spheroid for cell-based therapies using label-free ghost cytometry sorting
Author Affiliations & Notes
  • Yasuaki Iwama
    BDR, Rikagaku Kenkyujo, Wako, Saitama, Japan
    Ophthalmology, Osaka Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Suita, Osaka, Japan
  • Tomohiro Masuda
    BDR, Rikagaku Kenkyujo, Wako, Saitama, Japan
    Kobe Shiritsu Kobe Eye Center Byoin, Kobe, Hyogo, Japan
  • Hiroko Nomaru
    THINKCYTE, Tokyo, Kanto, Japan
  • Yoko Kawamura
    THINKCYTE, Tokyo, Kanto, Japan
  • Yuri Murata
    THINKCYTE, Tokyo, Kanto, Japan
  • Kohji Nishida
    Ophthalmology, Osaka Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Suita, Osaka, Japan
  • Michiko Mandai
    Kobe Shiritsu Kobe Eye Center Byoin, Kobe, Hyogo, Japan
    BDR, Rikagaku Kenkyujo, Wako, Saitama, Japan
  • Footnotes
    Commercial Relationships   Yasuaki Iwama None; Tomohiro Masuda None; Hiroko Nomaru THINKCYTE, Code E (Employment); Yoko Kawamura THINKCYTE, Code E (Employment), THINKCYTE, Code P (Patent); Yuri Murata THINKCYTE, Code E (Employment); Kohji Nishida None; Michiko Mandai None
  • Footnotes
    Support  This research was supported by AMED grant JP13bm0204002.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3691. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yasuaki Iwama, Tomohiro Masuda, Hiroko Nomaru, Yoko Kawamura, Yuri Murata, Kohji Nishida, Michiko Mandai; Stable production of hESC/iPSC-derived retinal progenitor spheroid for cell-based therapies using label-free ghost cytometry sorting. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3691.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Human iPSC-derived retinal organoid sheets were used as a graft in the recent clinical trial. Although they showed functional potency in preclinical animal studies, the size of individual sheets is up to about 1.0mm2. The goal of this research is to obtain retinal progenitor cells in the early differential stage, which can be used to prepare a larger sheet of the desired size. To avoid the risk of contamination by unwanted factors, label-free sorting is a desirable solution to enrich target cells. Thus, we constructed the label-free ghost cytometry (LFGC) sorting system and studied LFGC-sorted retinal spheroids in vitro and after transplantation.

Methods : RAX::Venus cell line and CRX::Venus cell line (both hESC-KhES-1 cell lines), and hiPSC-WJs531 cell line were differentiated into retinal organoids. We first trained a classifier based on support vector machine by obtaining GC waveforms of the RAX::Venus cell line on differentiation day (DD) 25. We then conducted LFGC-based sorting of the dissociated single cells from retinal organoids of the above cell lines at DD25. We defined the sorted cells as Sorted, the others as Waste, and unsorted cells preserved on ice as Control. The expressions of the marker genes of retinal progenitor cells and other cell types were tested by reverse transcription real-time quantitative PCR in each group. Spheroids were formed from the cells of each group and evaluated by immunohistochemistry (IHC) at DD60-70. iPSC-derived spheroids were also transplanted at around DD60 into the retinal degeneration model nude rats and evaluated by IHC at 4-5 months after surgery.

Results : With GC, the mean area under the receiver operating characteristic curve (ROC-AUC) for the classification of RAX::Venus++ cells and the others was 0.73 ± 0.01 (range; 0.71-0.76). Retinal progenitor marker genes were increased while non-retinal genes were decreased in Sorted compared to Control, which was reversed in the Waste. Using IHC, DD60-70 Sorted spheroids reproducibly included the retinal region, while Waste and Control spheroids became non-retinal tissue. Grafted spheroids survived and developed mature photoreceptors in the degenerating host retina.

Conclusions : LFGC-based sorting reproducibly enriched retinal progenitor cells of several different cell lines. These enriched cells can be used to prepare a larger graft sheet for cell-based therapies.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×